Why is IL-17A inhibition effective in PMR but not in GCA?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?

How do you approach requests for clearance for renal transplant in a patient with ANCA vasculitis who is on maintenance rituximab?

How would you manage an elderly patient with PAN who previously required bowel resection, and then develops mononeuritis multiplex on methotrexate and low dose prednisone ?

For patients with definite UIP and MPO-ANCA-associated vasculitis limited to the lungs (without systemic manifestations), what is the role of immunosuppression?

4

Does significant eosinophilia (8-44%) in a patient with suspected granulomatosis with polyangiitis (GPA) based on sinusitis, pulmonary nodules and positive PR3 change your management approach?

1 Answers

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service